Literature DB >> 26350521

Simulation of PET scan timings for receptor occupancy studies of CNS drugs: a simple fixed-time design performed as well as scattered time point designs.

Jongtae Lee1, Sangil Jeon2, Taegon Hong1, Seunghoon Han1, Dong-Seok Yim3.   

Abstract

PURPOSE: This study aimed to determine the effect of PET scan timings on the reliability of occupancy parameter estimates and to identify the scan timing design that gives the most reliable occupancy parameter estimates.
METHODS: We compared the performance of designs with various sets of sampling time points using the stochastic simulation and estimation method in Perl-speaks-NONMEM. Biases, relative standard errors, relative estimation errors, and root mean square errors were used to compare the performance of designs.
RESULTS: Unlike the results of a previous report, we found that rather complicated designs where each subject or group of subjects are allocated to different scan timings were not superior to the simple, conventional fixed-time designs regardless of whether effect compartment or receptor binding models were used.
CONCLUSIONS: We conclude that the conventional fixed-time designs that have been used so far may give robust PD parameter estimates for occupancy data obtained from human PET studies of CNS drugs.

Entities:  

Keywords:  Modeling; Occupancy; PET; Simulation

Mesh:

Substances:

Year:  2015        PMID: 26350521     DOI: 10.1007/s00228-015-1933-9

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming.

Authors:  Lars Lindbom; Jakob Ribbing; E Niclas Jonsson
Journal:  Comput Methods Programs Biomed       Date:  2004-08       Impact factor: 5.428

2.  Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationship.

Authors:  Euitae Kim; Oliver D Howes; Bo-Hyung Kim; Jae Min Jeong; Jae Sung Lee; In-Jin Jang; Sang-Goo Shin; Federico E Turkheimer; Shitij Kapur; Jun Soo Kwon
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-21       Impact factor: 6.200

3.  Adaptive-optimal design in PET occupancy studies.

Authors:  S Zamuner; V L Di Iorio; J Nyberg; R N Gunn; V J Cunningham; R Gomeni; A C Hooker
Journal:  Clin Pharmacol Ther       Date:  2010-03-24       Impact factor: 6.875

4.  Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers.

Authors:  K S Lim; J S Kwon; I-J Jang; J M Jeong; J S Lee; H W Kim; W J Kang; J-R Kim; J-Y Cho; E Kim; S Y Yoo; S-G Shin; K-S Yu
Journal:  Clin Pharmacol Ther       Date:  2007-02       Impact factor: 6.875

5.  Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats.

Authors:  Martin Johnson; Magdalena Kozielska; Venkatesh Pilla Reddy; An Vermeulen; Cheryl Li; Sarah Grimwood; Rik de Greef; Geny M M Groothuis; Meindert Danhof; Johannes H Proost
Journal:  Pharm Res       Date:  2011-06-07       Impact factor: 4.200

6.  The advantage of using positron emission tomography in drug research.

Authors:  L Farde
Journal:  Trends Neurosci       Date:  1996-06       Impact factor: 13.837

Review 7.  Positron emission tomography studies of dopamine-enhancing drugs.

Authors:  J S Fowler; N D Volkow; Y S Ding; G J Wang; S Dewey; M W Fischman; R Foltin; R Hitzemann
Journal:  J Clin Pharmacol       Date:  1999-08       Impact factor: 3.126

Review 8.  Measuring receptor occupancy with PET.

Authors:  A v Waarde
Journal:  Curr Pharm Des       Date:  2000-11       Impact factor: 3.116

9.  Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET.

Authors:  Khanum Ridler; Roger N Gunn; Graham E Searle; Julien Barletta; Jan Passchier; Luanna Dixson; William A Hallett; Sharon Ashworth; Frank A Gray; Clare Burgess; Italo Poggesi; Jonathan N Bullman; Emiliangelo Ratti; Marc A Laruelle; Eugenii A Rabiner
Journal:  J Psychopharmacol       Date:  2014-01-15       Impact factor: 4.153

10.  Monoamine transporter occupancy of a novel triple reuptake inhibitor in baboons and humans using positron emission tomography.

Authors:  Robert A Comley; Cristian A Salinas; Mark Slifstein; Marcella Petrone; Carmine Marzano; Idriss Bennacef; Paul Shotbolt; Jasper Van der Aart; Marta Neve; Laura Iavarone; Roberto Gomeni; Marc Laruelle; Frank A Gray; Roger N Gunn; Eugenii A Rabiner
Journal:  J Pharmacol Exp Ther       Date:  2013-05-17       Impact factor: 4.030

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.